All In MedTech

FDA Clearance Tracker · P990004-S039

SURGIFOAM Absorbable Gelatin Sponge, U.S.P.

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 19, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 19, 2021

Approved

Time to decision

515 days

Received May 22, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P990004-S039
Device name
SURGIFOAM Absorbable Gelatin Sponge, U.S.P.
Applicant location
Soeborg
Received
May 22, 2020
Decided
Oct 19, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P990004

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

Approval for addition of an alternate sterilization site and a change to the sterilization dosage for SURGIFOAM Absorbable Gelatin Sponge (Oral Sponge and Hemorrhoidectomy Sponge) and SURGIFOAM® Absorbable Gelatin Powder

Source documents

Other decisions for Ferrosan Meidcal Devices A/S

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.